false
Hamburger Menu
Catalog
Dirty Drugs -- Electrophysiologic Complications of ...
Dirty Drugs -- Electrophysiologic Complications of Cancer Treatments
Description
Cardio-oncology is a rapidly growing specialty due to the increasing number of cancer treamtents and cancer survivors. Arrhythmias are some fo the most common cardiovascular complications observed in cancer patients. Managing cancer treatment associated arrhythmias can be complicated and requites a collaborative and nuanced aproach to care. In this session, attendees will learn about cancer treatments that cause arrhythmias and how to best manage and mitigate these toxicities.
Learning Objectives
List cancer treatments that are associated with arrhythmias
Define how to manage cancer treatment-associated arrhythmias
Summarize monitoring and risk mitigation strategies for arrhythmias in cancer patients.
Session Chair(s)
Estelle Torbey, MD
James Tisdale, BPharm, PharmD
Presentation
With Every Beat of My Heart -- Pearls and Pitfalls of Managing Atrial Arrhythmias in Cancer Patients
Presenter(s)
:
Michael G. Fradley, MD
Danger Danger Everywhere -- Ventricular Arrhythmias and QT Prolongation in Malignancy
Presenter(s)
:
Zain Ul Abideen Asad, MD, MS
Slow It Down -- Bradycardia and Conduction System Disease in Cancer
Presenter(s)
:
Ioanna Kosmidou
I Am a Place Called Vertigo: Autonomic Dysfunction in Cancer
Presenter(s)
:
Kaveh Karimzad, MD
Disclosures
Michael Fradley
:
Abbott Medical (Honoraria/Speaking/Consulting Fee -
Speaking and Teaching
)
Novartis (Honoraria/Speaking/Consulting Fee -
Consulting
)
Medtronic (Research (Contracted Grants for PIs and Named Investigators only) -
Research
)
Myovant (Honoraria/Speaking/Consulting Fee -
Membership on Advisory Committees or Review Panels
)
AstraZeneca (Honoraria/Speaking/Consulting Fee -
Membership on Advisory Committees or Review Panels
)
Zoll Medical Corporation (Honoraria/Speaking/Consulting Fee -
Speaking and Teaching
)
AstraZeneca (Research (Contracted Grants for PIs and Named Investigators only) -
Research
)
Zain Ul Abideen Asad
:
Nothing Relevant to Disclose
Ioanna Kosmidou
:
Pfizer, Inc. (Honoraria/Speaking/Consulting Fee -
Membership on Advisory Committees or Review Panels
)
Amgen (Research (Contracted Grants for PIs and Named Investigators only) -
Research
)
Sanofi (Honoraria/Speaking/Consulting Fee -
Speaking and Teaching
)
abbott (Speakers' Bureau -
Speaking and Teaching
)
Kaveh Karimzad
:
Nothing Relevant to Disclose
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here
.
Education Framework
General Concepts
-- Pathophysiological Basis of Cardiac Arrhythmias and Basic EP
-- 7. Know the systemic disorders, as well as metabolic and electrolyte abnormalities associated with arrhythmias and conduction abnormalities.
Summary
Availability:
No future session
Cost:
FREE
Credit Offered:
No Credit Offered
×
Dirty Drugs -- Electrophysiologic Complications of Cancer Treatments Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English